An experimental compound reduced the cell death, inflammation, and organ damage seen with diabetes.
Led by NYU Langone Health researchers, a new study in mice showed that a drug candidate prevented the interaction between two…
Category: 6. Health
-
Research shows the potential of structural nanomedicine in cancer treatment
In a promising advance for cancer treatment, Northwestern University scientists have re-engineered the molecular structure of a common chemotherapy drug, making it dramatically more soluble and effective and less toxic.
In the…
Continue Reading
-
WCC leads workshop on HIV and faith in Nicaragua
The second day focused on leadership for sustainability, where Ross introduced the four WCC theological manuals: HIV and Migration, Mental Health, Prevention, and HIV and Youth. “The response was extremely positive, and participants were eager…
Continue Reading
-
HPV Vaccination Shows Long-Term Cancer Benefits – Medscape
- HPV Vaccination Shows Long-Term Cancer Benefits Medscape
- HPV vaccination can help prevent rising cases of oral cancer Healthcare Radius
- Parental pushback threatens HPV protection Medical Xpress
- Get that HPV shot: HPV herd immunity doesn’t make…
Continue Reading
-
McDonald Criteria Updates Boost MS Diagnostic Specificity – Medscape
- McDonald Criteria Updates Boost MS Diagnostic Specificity Medscape
- Radiomics on Spinal Cord MRI May Offer Superior MS Assessment The American Journal of Managed Care® (AJMC®)
- New guidelines help doctors diagnose MS earlier and more accurately
Continue Reading
-
Nanostructured Chemotherapy Boosts Efficacy and Reduces Toxi
In a promising advance for cancer treatment, Northwestern University scientists have re-engineered the molecular structure of a common chemotherapy drug, making it dramatically more soluble and effective and less toxic.
In the new study,…
Continue Reading
-
Just a moment…
Just a moment… This request seems a bit unusual, so we need to confirm that you’re human. Please press and hold the button until it turns completely green. Thank you for your cooperation!
Continue Reading
-
Omacetaxine and Venetoclax Show Benefits in MDS, No Improvement in AML | Targeted Oncology
A phase 1b/2 trial (NCT04874194) revealed that the combination treatment of omacetaxine and venetoclax (Venclexta) in patients with relapsed/refractory acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) with RUNX1 mutation showed…
Continue Reading
-
Just a moment…
Just a moment… This request seems a bit unusual, so we need to confirm that you’re human. Please press and hold the button until it turns completely green. Thank you for your cooperation!
Continue Reading
-
Too few people with HIV receiving statins despite guideline changes
Progress towards wider use of statins in people with HIV has been modest and LDL cholesterol control remains suboptimal in people with HIV at higher risk of cardiovascular disease, studies presented at last week’s 20th European AIDS Conference…
Continue Reading